Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Richman Chemical, Inc. today announced a new Consulting Services Division to assist chemistry-based startups with evaluating new technologies and establishing strategic relationships with service providers, regulatory experts, technology licensing ...
read more
Richman Chemical Inc. (RCI), a custom synthesis, chemical manufacturing, and raw materials sourcing provider to the life science and chemical industries, announces a new partnership with Auditweaver, LLC., a specialty consultancy firm to the life ...
read more
Monday, November 04, 2013
Almac’s Clinical Services Business Unit is delighted to announce that Richard Segiel, Jr. has joined the company as Vice President of Business Development for the United States. He brings with him 23 successful years of experience in the contract ...
read more
Chiltern, a global clinical research organization, announced that Richard Pilnik has been named chairman. In 2015, he joined the Chiltern board of directors and has made significant contributions to the company’s strategy and future direction. Pilnik...
read more
Rich Pharmaceuticals has entered into an additional agreement with Theradex Systems, a global Contract Research Organization, to assist the company in submitting a protocol to the US FDA for Hodgkin's Lymphoma under the company's existing ...
read more
Wednesday, December 06, 2017
Rich Pharmaceuticals has retained IND 2 Results, Atlanta Georgia, to serve as its Contact Research Organization.
read more
Rich Pharmaceuticals, a biopharmaceutical company focused on developing and commercializing innovative therapies in oncology, has retained the services of an Asian contract research organization CMIC Asia-Pacific, Pte. Ltd., to run Rich's upcoming ...
read more
Rich Pharmaceuticals, a biopharmaceutical company focused on developing and commercializing innovative therapies in oncology, has extended its agreement with Theradex Systems, Inc., a global Contract Research Organization ("CRO"), to manage the ...
read more
After the sale of its Chemical Development Division to Olon S.p.A., Ricerca Biosciences is being renamed Concord Biosciences.
read more
Ricerca Biosciences, an integrated preclinical contract research organization (CRO) providing services to the biopharmaceutical industry, announces Dr. G. Lynn Miesel as the new technical director.
read more
Emmes announced today that Rhonda Henry has joined the company as President of Emmes BioPharma.
read more
Rho is coordinating a new study to help determine the rate of the new coronavirus infection in children and their family members in the U.S.
read more
Thursday, November 02, 2017
Rho announced plans to build a new 159,000-square-foot headquarters building in Research Triangle Park, North Carolina.
read more
Wednesday, October 24, 2018
Rho is part of a newly published study that is helping medical professionals better understand pediatric heart transplantation.
read more
Wednesday, March 12, 2014
Rho, a full-service contract research organization (CRO), is showcasing its 30-year history of success in drug development strategies and services at the Outsourcing in Clinical Trials (OCT) Southeast conference, which is being held in Rho’s backyard...
read more